Dr.Reddy's is an India-based pharmaceutical company that manufactures and markets medicines, active pharmaceutical ingredients and intermediates for for the healthcare sector.

Intellectual Property Counsel

Maintenance Technician

Team Member - Warehouse

Lead, Commercial Analytics & Forecasting

Dr. Reddy's Laboratories

SCINTIFIC BUSINESS OFFICER

Field sales officer

Packaging specialist(I1) - Packaging Development

Lead - Packaging Development - India RnD

Scientist -II

Research Scientist / Head Packaging

Executive Officer

TRAINEE

Regional Business Manager

ABM Hematology

Scientific Business Manager

Hospital Executive SBH

Pharmacist

Analytical Scientist

QA Associate

Team Lead Production

Executive Production

Senior Officer Production

Officer Production

Sales Manager

Regional Manager

REGIONAL BUSINESS MANAGER

Regional Sales manager

Area sales manager

Territory Business Manager

Senior Director || R&D Strategy, Programs| Integrated Product Development Organization

Global Strategic Program Manager, Office of Global Head of API, OSD and Scientific Affairs

Senior Manager (Strategy and Portfolio) and EA to the Chairman and Managing Director

Senior Scientist

PhD Candidate

System Analyst

Project Manager

Management Trainee

Summer Intern

QA Team Member

QA Officer

ex : IPQA Officer

Principal Scientist (Associate Director) Formulation Research & Development

Manager Pilot Plant and Technology Transfer

Manager New Product Development

Manager And Formulation Head

Sr Principal Scientist

Research Associate / Asst Manager

Sr Officer - Formulation Development

Officer - R&D (Formulations)

Route 53

Outlook

Microsoft Office 365

Google Cloud Hosting

Pardot

Amazon SES

Lead- Formulations and Drug product Development

Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors.Syngene's more than 6000 scientists offer both skills and the capacity to deliver great science, robust data security, and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation.With a combination of dedicated research facilities for Amgen, Baxter, and Bristol-Myers Squibb as well as 2 Mn sq. ft of specialist discovery, development and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as well as multinationals, including GSK, Zoetis and Merck KGaA.For more details, visit www.syngeneintl.com or write to us at bdc@syngeneintl.com

BD Product Manager

Director - Business Development (UK, Ireland and Scandinavia)

Syngene International Limited

SendInBlue

Amazon AWS

Oracle Cloud

VueJS

Senior Research Investigator

Scientist

Research Scholar

Biocon: Enhancing Global HealthcareBiocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global healthcare through innovative and affordable biopharmaceuticals, we have enabled access to advanced therapies for diseases that are chronic, where medical needs are largely unmet and treatment costs are high. The early anticipation of the increasing dominance of biologics in global development pipelines helped us to be ahead of the curve in crafting a differentiated product portfolio based on fermentation and recombinant technologies, which straddles fermentation-derived small molecules and biologics, both novel as well as biosimilars.The significant brand equity that we have built worldwide for our small molecule APIs across statins, immunosuppresants and other specialty products has made us a leading global supplier of these products.We have also built one of the largest and most diverse biosimilar pipelines, spanning insulins, monoclonal antibodies and other recombinant proteins that address critical chronic diseases such as diabetes, cancer and autoimmune disorders.Ranked among the Top 3 biosimilar players globally for rh-insulin and insulin glargine in volume terms, we are the first Indian company to launch a biosimilar in Japan with Insulin Glargine, which also has been approved for sale in EU and Australia. Our insulin products have made a difference to the lives of millions of people with diabetes across the globe. We now aim to provide our insulin products to ‘one in five' people with diabetes in need of insulin-based therapy anywhere in the world within the next 10 years.We are also making a huge impact in the area of cancer care. Our biosimilar Trastuzumab, which was the first to be approved anywhere in the world and launched in India in 2014, has helped treat several thousand HER2-positive metastatic breast cancer patients. We are also the first company from India to get its biosimilar approved by the USFDA; Ogivri™, co-developed by Biocon and Mylan, is the first biosimilar Trastuzumab to be approved in the US. In addition to Trastuzumab, several of our biosimilar assets are on track for anticipated regulatory approvals in developed markets.We are also developing a pipeline of patented biologics to address global unmet medical needs. We have successfully launched a couple of novel biologics in India: Nimotuzumab for the treatment of head and neck cancer and Itolizumab to tackle psoriasis. Besides these, we have a basket of novel assets are under various stages of clinical development, including a high potential oral insulin.Through our subsidiary, Syngene, we offer a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) to the global life sciences sector.Ranked by the prestigious Science magazine among the Top 10 Best employers in the biotech industry, Biocon is passionately pursuing a mission to rationalize healthcare spends, enhance access to life-saving therapies and make a significant impact to global healthcare through ‘blockbuster' drugs with the potential to benefit a billion patients.

Suman Labala

Lead- Formulations and Drug product Development at Dr. Reddy's Laboratories

Suman Labala's Professional Contact Details

Suman Labala's Current Company Details

Dr. Reddy's Laboratories

Suman Labala's Work History and Education

Frequently Asked Questions about Suman Labala

What company does Suman Labala work for?

What is Suman Labala's role at Dr. Reddy's Laboratories?

What is Suman Labala's email address?

What is Suman Labala's business email address?

What is Suman Labala's HQ phone number?

What industry does Suman Labala work in?

Who are Suman Labala's colleagues?

Colleagues at Dr. Reddy's Laboratories

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?